EXPRESSION OF IMMUNOGLOBULIN LIGHT CHAIN GENES IN STEREOTYPED CASES FROM UKRAINIAN COHORT OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

Authors

  • I. ABRAMENKO Department of Clinical Immunology, National Research Center for Radiation Medicine, Hematology and Oncology, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • N. BILOUS Department of Clinical Immunology, National Research Center for Radiation Medicine, Hematology and Oncology, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • Z. MARTINA Department of Hematology, National Research Center for Radiation Medicine, Hematology and Oncology, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • I. DYAGIL Department of Hematology, National Research Center for Radiation Medicine, Hematology and Oncology, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • A. CHUMAK Department of Clinical Immunology, National Research Center for Radiation Medicine, Hematology and Oncology, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine

DOI:

https://doi.org/10.15407/exp-oncology.2024.03.202

Keywords:

chronic lymphocytic leukemia, stereotyped subset, IGK/LV genes

Abstract

Background. Analysis of immunoglobulin heavy chain gene (IGHV) rearrangements expressed in chronic lymphocytic leukemia (CLL) cells has provided insights into the B-cell receptor (BCR) repertoire in CLL. In more than 40% of CLL patients, (quasi)identical or stereotyped BCR is expressed. The recent data point at the non-stochastic expression of immunoglobulin light lambda (IGLV) or kappa (IGKV) chains as well. Several pairs of IGHV and IGK/LV have been described for some major stereotyped subsets, but most subsets have not been characterized. Aim. To study the IGK/LV gene expression in stereotyped CLL cases. Materials and Methods. Analysis was performed in a group of 105 CLL patients with stereotyped BCR. The cases with stereotyped BCRs were identified according to Agathangelidis et al. (2021). The IGHV and IGK/LV gene expressions were studied by a polymerase chain reaction followed by direct sequencing. Results. The expression of the IGK/LV genes in the most presented major stereotyped subsets (#1, #2, #3C3, #4, #6, #28а) was in agreement with the data reported by other authors. For the cases of subsets #5b, #9D1, #9D4, #16, #50, #59, and #77, differences were found. The new data on the IGK/LV gene expression in 55 minor clusters were presented. A number of patterns of the IGK/LV gene expression depending on the phylogenetic clan and mutational status of the IGHV genes have been described. Conclusion. The non-stochastic distribution of the IGKV/LV gene expression in the individual stereotyped subsets was confirmed. Taking into account the complementary role of the light chains in antigen recognition by the clonotypic BCRs, it was suggested that the subsets with the heterogeneous IGK/LV expression might be reclassified and divided into separate subgroups based on the IGHV and IGK/LV association.

References

Kipps TJ, Tomhave E, Pratt LF, et al. Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 1989;86(15):5913­5917. https://doi.org/10.1073/pnas.86.15.5913

Tobin G, Thunberg U, Johnson A, et al. Chronic lymphocytic leukemias utilizing the VH3­21 gene display highly restricted Vλ2­14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood. 2003;101(12):4952­4957.

Ten Hacken E, Gounari M, Ghia P, Burger JA. The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia. Leukemia. 2019;33(2):287­298. https://doi.org/10.1038/s41375­018­0303­x

Agathangelidis A, Chatzidimitriou A, Gemenetzi K, et al. Higher­order connections between stereotyped subsets: implications for improved patient classification in CLL. Blood. 2021;137(10):1365­1376. https://doi.org/10.1182/ blood.2020007039

Bilous NI, Abramenko IV, Chumak AA, et al. Stereotyped cases in Ukrainian cohort of chronic lymphocytic leuke­ mia patients depending on the ionizing radiation exposure. Probl Radiac Med Radiobiol. 2022; 27:307­323. https:// doi.org/10.33145/2304­8336­2022­27­307­323.

Vlachonikola E, Sofou E, Chatzidimitriou A, et al. The significance of B­cell receptor stereotypy in chronic lympho­ cytic leukemia: biological and clinical implications. Hematol Oncol Clin North Am. 2021;35(4):687­702. https://doi. org/10.1016/j.hoc.2021.03.003.

Agathangelidis A, Chatzikonstantinou T, Stamatopoulos K. B cell receptor immunoglobulin stereotypy in chronic lymphocytic leukemia: Key to understanding disease biology and stratifying patients. Semin Hematol. 2024;61(2):91­ 99. https://doi.org/10.1053/j.seminhematol.2023.12.005

Stamatopoulos R, Belessi C, Moreno C, et al. Over 20% of patients with chronic lymphocytic leukemia carry ste­ reotyped receptors: Pathogenetic implications and clinical correlations. Blood. 2007;109(1):259­270. https://doi. org/10.1182/blood­2006­03­012948.

Tobin G, Thunberg U, Johnson A, et al. Chronic lymphocytic leukemias utilizing the VH3­21 gene display highly restricted Vlambda2­14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood. 2003;101(12):4952­4957. https://doi.org/10.1182/blood­2002­11­3485

Vergani S, Bagnara D, Agathangelidis A, et al. CLL stereotyped B­cell receptor immunoglobulin sequences are recur­ rent in the B­cell repertoire of healthy individuals: Apparent lack of central and early peripheral tolerance censoring. Front Oncol. 2023;13:1112879. https://doi.org/10.3389/fonc.2023.1112879.

Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46:219­234.

Rai KR. A critical analysis of staging in CLL. In: Gale RP, Rai KR, eds. CLL Recent Progress and Future Directions, vol. 59. UCLA Symposia on Molecular and Cellular Biology. New York: Alan R. Liss; 1987. p. 253.

Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from amultivariatesurvivalanalysis.Cancer.1981;48:198-206.https://doi.org/10.1002/1097­0142(19810701)48:1<198::aid­ cncr2820480131>3.0.co;2­v.

Abramenko I, Bilous N, Chumak A, et al. Chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chernobyl NPP accident­­with focus on immunoglobulin heavy chain gene analysis. Leuk Res. 2008;32:535­ 545. https://doi.org/10.1016/j.leukres.2007.08.013

Hamblin TJ, Davis Z, Garddiner A, et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94(6):1848­1854.

Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94(6):1840­1847.

van Dongen JJ, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T­cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED­2 Concerted Action BMH4­CT98­3936. Leukemia. 2003;17(12):2257­2317. https://doi. org/10.1038/sj.leu.2403202

Hadzidimitriou A, Darzentas N, Murray F, et al. Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia. Blood. 2009;113(2):403­411. https://doi. org/10.1182/blood­2008­07­166868

Widhopf GF 2nd, Goldberg CJ, Toy TL, et al. Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3. Blood. 2008;111(6):3137­ 3144. https://doi.org/10.1182/blood­2007­02­073130.

Banach BB, Cerutti G, Fahad AS, et al. Paired heavy­ and light­chain signatures contribute to potent SARS­CoV­2 neu­ tralization in public antibody responses. Cell Rep. 2021;37(1):109771. https://doi.org/10.1016/j.celrep.2021.109771

Patel A, Kumar S, Lai L, et al. Light chain of a public SARS­CoV­2 class­3 antibody modulates neutralization against Omicron. Cell Rep. 2023;42(9):113150. https://doi.org/10.1016/j.celrep.2023.113150

Downloads

Published

19.12.2024

How to Cite

ABRAMENKO, I., BILOUS, N., MARTINA, Z., DYAGIL, I., & CHUMAK, A. (2024). EXPRESSION OF IMMUNOGLOBULIN LIGHT CHAIN GENES IN STEREOTYPED CASES FROM UKRAINIAN COHORT OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS. Experimental Oncology, 46(3), 202–208. https://doi.org/10.15407/exp-oncology.2024.03.202

Issue

Section

Original contributions

Most read articles by the same author(s)